325 related articles for article (PubMed ID: 26449784)
1. High preoperative neutrophil-lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy.
Lee H; Jeong SJ; Hong SK; Byun SS; Lee SE; Oh JJ
World J Urol; 2016 Jun; 34(6):821-7. PubMed ID: 26449784
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer.
Jang WS; Cho KS; Kim KH; Yoon CY; Kang YJ; Lee JY; Ham WS; Rha KH; Hong SJ; Choi YD
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):298-304. PubMed ID: 27349499
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy.
Zhang GM; Zhu Y; Ma XC; Qin XJ; Wan FN; Dai B; Sun LJ; Ye DW
Medicine (Baltimore); 2015 Oct; 94(41):e1473. PubMed ID: 26469891
[TBL] [Abstract][Full Text] [Related]
4. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
5. Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomy.
Özsoy M; Moschini M; Fajkovic H; Soria F; Seitz C; Klatte T; Gust K; Briganti A; Karakiewicz PI; Roupret M; Kramer G; Shariat SF
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):100-105. PubMed ID: 29230007
[TBL] [Abstract][Full Text] [Related]
6. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
7. The Values of Systemic Immune-Inflammation Index and Neutrophil-Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy.
Wang S; Yang X; Yu Z; Du P; Sheng X; Cao Y; Yan X; Ma J; Yang Y
Front Oncol; 2022; 12():907625. PubMed ID: 35719913
[TBL] [Abstract][Full Text] [Related]
8. The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6.
Wang H; Gu L; Wu Y; Feng D; Duan J; Wang X; Huang Y; Wu S; Chen J; Luo G; Zhang X
BMC Cancer; 2017 Sep; 17(1):629. PubMed ID: 28874127
[TBL] [Abstract][Full Text] [Related]
9. The preoperative neutrophil-to-lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy.
Cao Z; Ji J; Zhang C; Wang F; Xu H; Yu Y; Sun Y
Cancer Med; 2019 Mar; 8(3):1004-1012. PubMed ID: 30693666
[TBL] [Abstract][Full Text] [Related]
10. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
[TBL] [Abstract][Full Text] [Related]
11. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of neutrophil-to-lymphocyte and platelets-to-lymphocyte ratio in predicting biochemical recurrence post robotic prostatectomy.
Zanaty M; Ajib K; Alnazari M; El Rassy E; Aoun F; Zorn KC; El-Hakim A
Biomark Med; 2018 Aug; 12(8):841-848. PubMed ID: 30019909
[TBL] [Abstract][Full Text] [Related]
13. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
[TBL] [Abstract][Full Text] [Related]
14. Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy.
Kang M; Jeong CW; Ku JH; Kwak C; Kim HH
PLoS One; 2015; 10(3):e0122438. PubMed ID: 25803284
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for localized prostate cancer.
Jang WS; Cho KS; Kim MS; Yoon CY; Kang DH; Kang YJ; Jeong WS; Ham WS; Choi YD
Oncotarget; 2017 Feb; 8(7):11778-11787. PubMed ID: 28052031
[TBL] [Abstract][Full Text] [Related]
16. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
Boorjian SA; Bianco FJ; Scardino PT; Eastham JA
BJU Int; 2005 Oct; 96(6):773-6. PubMed ID: 16153197
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer.
Kwon YS; Han CS; Yu JW; Kim S; Modi P; Davis R; Park JH; Lee P; Ha YS; Kim WJ; Kim IY
Clin Genitourin Cancer; 2016 Feb; 14(1):e1-8. PubMed ID: 26341038
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.
Park JJ; Kim CK; Park SY; Park BK; Lee HM; Cho SW
AJR Am J Roentgenol; 2014 May; 202(5):W459-65. PubMed ID: 24758681
[TBL] [Abstract][Full Text] [Related]
19. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
[TBL] [Abstract][Full Text] [Related]
20. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
